How Kämper Drahtumformtechnik accelerated automation and boosted efficiency with innoscriptaRead the story
A €1.9 trillion R&D market still runs on outdated tools. We're transforming how 2,500+ companies manage research, documentation, and funding, with measurable outcomes and a clear path to growth.
Despite billions invested in research and development, most companies still manage their R&D operations in Excel and disconnected tools. The result: limited visibility, missed deadlines, and significant opportunity costs that compound over time.
Most enterprise software today operates in isolated systems with fragmented data and disconnected workflows. We believe the next generation of enterprise software will be built around connected data structures, integrated workflows and shared intelligence. Starting with R&D, Clusterix is evolving into a central platform layer connecting processes, documentation and enterprise data across the organization.
From planning to documentation to funding, innoscripta brings every stage of R&D into one integrated system, replacing spreadsheets, disconnected tools, and manual processes.
Where outdated tools create cost and risk, innoscripta unlocks performance, efficiency, and returns.
Deep R&D and regulatory expertise
Years of specialized experience across R&D tax credits, documentation requirements, and compliance frameworks. Established relationships with tax authorities and a proven track record of successful claims give clients confidence that competitors with shallower domain knowledge can't match.
Proprietary technology and deep integrations
AI-driven automation streamlines R&D tax credit documentation, while seamless integrations with clients' project management, time tracking, and accounting systems reduce manual work. Replicating this requires significant investment and technical expertise that competitors lack.
High switching costs lock in long-term value
Once clients onboard their detailed financial and project data, switching providers becomes costly, risky, and disruptive. This structural advantage drives retention, supports recurring revenue, and is reflected in our churn rate below 2%.
Customization at scale
Industry-specific and jurisdiction-specific reporting tools, paired with scalable infrastructure that handles enterprise-volume clients without compromising quality. The combination of customization and scale is rare in this category and creates barriers for both competitors and new entrants.
Governments worldwide use R&D tax credits to attract and retain innovative companies, offering allowances, exemptions, deductions, and direct credits that reduce the cost of research and development. By lowering the financial burden of innovation, these incentives drive economic growth, productivity, and technological advancement on a national scale.
To qualify for these credits, companies must maintain detailed, traceable, and audit-ready documentation of every R&D expense. Without it, claims fall apart under scrutiny, exposing companies to penalties, legal challenges, and rejected applications. innoscripta is built to handle exactly this complexity.
Tax authorities worldwide are tightening documentation requirements, narrowing qualifying activities, and increasing audit scrutiny. The OECD is leading standardization efforts across member nations, raising the global bar for compliance.
Stricter documentation in the UK
Since August 2023, HM Revenue & Customs requires significantly more detailed information for every R&D claim submitted, raising the bar for evidence and substantiation.
What additional information is required for R&D claims submitted from 8 August 2023?
Key questions about innoscripta and the R&D market.
Max Hunger
Head of Investor Relations
